| Schedule of Operating Results of Operations Treated as Discontinued Operations |
The following table summarizes the financial results of our discontinued operations for the three and six months ended June 30, 2026 and June 29, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | June 30, 2026 | | June 29, 2025 | | June 30, 2026 | | June 29, 2025 | | | | | | | | | | | | | | Net revenues | $ | 318,767 | | | $ | 338,364 | | | $ | 602,584 | | | $ | 624,775 | | | | | Cost of goods sold | 158,968 | | | 173,109 | | | 305,876 | | | 325,512 | | | | | Gross profit | 159,799 | | | 165,255 | | | 296,708 | | | 299,263 | | | | | Selling, general and administrative expenses | 74,368 | | | 77,582 | | | 140,553 | | | 147,510 | | | | | Research and development expenses | 17,339 | | | 12,033 | | | 31,608 | | | 23,142 | | | | | | | | | | | | | | Restructuring charges, separation costs and impairment charges (1) | 7,911 | | | 11,472 | | | 67,059 | | | 14,805 | | | | | Interest expense | 9 | | | 5 | | | 63 | | | 12 | | | | | Interest income | (82) | | | (414) | | | (186) | | | (843) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Income from discontinued operations before income taxes | 60,254 | | | 64,577 | | | 57,611 | | | 114,637 | | | | | | | | | | | | | | | Income tax expense | 2,323 | | | 10,172 | | | 2,996 | | | 17,563 | | | | | Income from discontinued operations | $ | 57,931 | | | $ | 54,405 | | | $ | 54,615 | | | $ | 97,074 | | | | | | | | | | | | | | | | | | | | | | | |
(1) For the three and six months ended June 30, 2026, we incurred separation costs of $29.0 million and $59.2 million, respectively, primarily related to consulting, legal, tax and other professional advisory services associated with the Strategic Divestitures. Additionally, we remeasured the valuation allowance related to the Acute Care and IU businesses component of the Strategic Divestitures, which resulted in a gain of $21.1 million for the three months ended June 30, 2026 and a charge of $7.9 million for the six months ended June 30, 2026. See below for further detail. For the three and six months ended June 29, 2025, we incurred separation costs of $11.6 million and $14.8 million, respectively. The following table summarizes the carrying amounts of the major classes of assets and liabilities classified as discontinued operations in the condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | | | ASSETS | | | | | Cash and cash equivalents | $ | 47,368 | | | $ | 51,168 | | | Accounts receivable, net | 242,618 | | | 225,326 | | | Inventories | 365,963 | | | 343,183 | | | Prepaid expenses and other current assets | 18,567 | | | 19,875 | | | Current assets of discontinued operations | 674,516 | | | 639,552 | | | Property, plant and equipment, net | 241,534 | | | 214,426 | | | Operating lease assets | 20,269 | | | 21,213 | | | Goodwill | 112,010 | | | 112,010 | | | Intangible assets, net | 832,571 | | | 832,626 | | | Deferred tax assets | 27,411 | | | 27,928 | | | Other assets | 5,220 | | | 2,893 | | | Valuation allowance on disposal group classified as held for sale | (754,964) | | | (747,070) | | | Assets of discontinued operations | $ | 1,158,567 | | | $ | 1,103,578 | | | LIABILITIES | | | | | Accounts payable | $ | 38,806 | | | $ | 37,478 | | | Accrued expenses | 32,351 | | | 29,629 | | | Payroll and benefit-related liabilities | 43,597 | | | 52,248 | | | Other current liabilities | 20,740 | | | 8,965 | | | Current liabilities of discontinued operations | 135,494 | | | 128,320 | | | Deferred tax liabilities | 31,638 | | | 31,801 | | | Non-current operating lease liability | 16,645 | | | 17,839 | | | Other non-current liabilities | 3,691 | | | 3,329 | | | | | | | Liabilities of discontinued operations | $ | 187,468 | | | $ | 181,289 | |
Cash flows attributable to discontinued operations are included in the condensed consolidated statements of cash flows. Significant non-cash operating and investing activities attributable to discontinued operations consisted of the following: | | | | | | | | | | | | | | | Six Months Ended | | June 30, 2026 | | June 29, 2025 | | | | | Depreciation expense | $ | — | | | $ | 12,743 | | | | Intangible asset amortization expense | — | | | 44,792 | | | | Impairment charges | 7,894 | | | — | | | | Expenditures for property, plant and equipment | 18,144 | | | 12,718 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|